Frequent coauthors
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17beta- hydroxysteroid dehydrogenase type I (17beta-HSD1), to their salts, to pharmaceutical preparations containing th…
The present invention relates to novel 3, 15 substituted estrone derivatives which represent inhibitory compounds of the 17Ã-hydroxysteroid dehydrogenase type I (17Ã-HSD1), to their salts, to pharmaceutical preparations containing these c…
3,15-substituted estrone compounds which act as inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), salts thereof, pharmaceutical preparations containing such compounds, processes for preparing such compounds, and therap…
3,15-substituted estrone compounds which act as inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), salts thereof, pharmaceutical preparations containing such compounds, processes for preparing such compounds, and therap…
3,15-substituted estrone compounds which act as inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), salts thereof, pharmaceutical preparations containing such compounds, processes for preparing such compounds, and therap…
3,15-substituted estrone compounds which act as inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), salts thereof, pharmaceutical preparations containing such compounds, processes for preparing such compounds, and therap…
3,15-substituted estrone compounds which act as inhibitors of 17beta-hydroxysteroid dehydrogenase type I (17beta-HSD1), salts thereof, pharmaceutical preparations containing such compounds, processes for preparing such compounds, and therap…